Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 20 articles:
HTML format



Single Articles


    February 2024
  1. VOELKER R
    What Is Ulcerative Colitis?
    JAMA. 2024 Feb 2. doi: 10.1001/jama.2023.23814.
    PubMed    


    November 2023
  2. SURAN M
    Highlights From Gastroenterology Week: New Crohn Disease Drug, Redefining Liver Disease, and More.
    JAMA. 2023 Nov 2. doi: 10.1001/jama.2023.19140.
    PubMed    


    September 2023
  3. GROS B, Kaplan GG
    Ulcerative Colitis in Adults: A Review.
    JAMA. 2023;330:951-965.
    PubMed     Abstract available


    March 2023
  4. HARRIS E
    Patients With Normal Gut Biopsy Still at Increased Risk of IBD.
    JAMA. 2023;329:875.
    PubMed    


  5. ZHANG S, Chen B, Wang B, Chen H, et al
    Effect of Induction Therapy With Olamkicept vs Placebo on Clinical Response in Patients With Active Ulcerative Colitis: A Randomized Clinical Trial.
    JAMA. 2023;329:725-734.
    PubMed     Abstract available


    April 2022
  6. VANDE CASTEELE N
    Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy and Control of Immune-Mediated Inflammatory Diseases.
    JAMA. 2022;327:1506.
    PubMed    


  7. JAVOR E, Hauser G, Skelin M
    Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy and Control of Immune-Mediated Inflammatory Diseases.
    JAMA. 2022;327:1505-1506.
    PubMed    


  8. SYVERSEN SW, Jahnsen J, Haavardsholm EA
    Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy and Control of Immune-Mediated Inflammatory Diseases-Reply.
    JAMA. 2022;327:1506-1507.
    PubMed    


    December 2021
  9. SYVERSEN SW, Jorgensen KK, Goll GL, Brun MK, et al
    Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
    JAMA. 2021;326:2375-2384.
    PubMed     Abstract available


    October 2021
  10. ABBASI J
    Vaccine-Induced SARS-CoV-2 Antibodies in Inflammatory Diseases.
    JAMA. 2021;326:1365.
    PubMed    


    September 2021
  11. SERKLAND TT, Skrede S, Berg JA
    Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases.
    JAMA. 2021;326:1068-1069.
    PubMed    


  12. LE TILLY O, Paintaud G, Ternant D
    Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases.
    JAMA. 2021;326:1069.
    PubMed    


  13. PAPAMICHAIL K, Dubinsky MC, Cheifetz AS
    Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases.
    JAMA. 2021;326:1067-1068.
    PubMed    


  14. SYVERSEN SW, Bolstad N, Haavardsholm EA
    Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases-Reply.
    JAMA. 2021;326:1069-1070.
    PubMed    


    July 2021
  15. SLOMSKI A
    Filgotinib Induces and Maintains Ulcerative Colitis Remission.
    JAMA. 2021;326:299.
    PubMed    


    May 2021
  16. BAYOUMY AB, de Boer NKH, Mulder CJJ
    Management of Crohn Disease.
    JAMA. 2021;325:1793-1794.
    PubMed    


  17. CUSHING K, Higgins PDR
    Management of Crohn Disease-Reply.
    JAMA. 2021;325:1794-1795.
    PubMed    


  18. CURTIS JR, Ogdie A, George MD
    Treatment Strategies for Patients With Immune-Mediated Inflammatory Diseases.
    JAMA. 2021;325:1726-1728.
    PubMed    


  19. SYVERSEN SW, Goll GL, Jorgensen KK, Sandanger O, et al
    Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
    JAMA. 2021;325:1744-1754.
    PubMed     Abstract available


    January 2021
  20. CUSHING K, Higgins PDR
    Management of Crohn Disease: A Review.
    JAMA. 2021;325:69-80.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.